Search

Your search keyword '"Rinaldi, Daisy"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Rinaldi, Daisy" Remove constraint Author: "Rinaldi, Daisy" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
34 results on '"Rinaldi, Daisy"'

Search Results

1. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

2. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression

3. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

4. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

5. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

6. Differential early subcortical involvement in genetic FTD within the GENFI cohort

9. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

10. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

11. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years

13. Brain Metabolic Profile in Presymptomatic GRN Carriers Throughout a 5-Year Follow-up.

15. MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

18. Plasma NfL levels and longitudinal change rates in and -associated diseases: from tailored references to clinical applications.

19. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration.

20. Plasma microRNA signature in presymptomatic and symptomatic subjects with -associated frontotemporal dementia and amyotrophic lateral sclerosis.

21. Using GENFI participant engagement to inform observational research and clinical trials.

24. Cognitive inhibition impairments in presymptomatic carriers.

25. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.

26. Neurite density is reduced in the presymptomatic phase of disease.

27. Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.

28. Low cancer prevalence in polyglutamine expansion diseases.

29. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.

31. Primary Progressive Aphasia Associated With Mutations: New Insights Into the Non-amyloid Logopenic Variant.

33. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers.

34. Novel VCP mutations expand the mutational spectrum of frontotemporal dementia.

Catalog

Books, media, physical & digital resources